Social Cognitive Theory-Based Education for Improving Health Outcomes in Older Adults (SCT-OLD)
Effect of a Social Cognitive Theory-Based Education Program on Self-Efficacy, Healthy Lifestyle Behaviors, and Health Literacy in Older Adults Attending Primary Care Centers: A Randomized Controlled Trial
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
This study is designed as a randomized controlled trial to evaluate the impact of a Social Cognitive Theory-based educational intervention on self-efficacy, healthy lifestyle behaviors, and health literacy among older adults. The study will be conducted in a primary care setting and will include individuals aged 65 years and older who meet the inclusion criteria and provide informed consent.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured education program based on Social Cognitive Theory, delivered in three weekly face-to-face sessions, each lasting approximately 30 minutes. The content of the program includes health promotion, healthy nutrition, physical activity, chronic disease management, self-efficacy enhancement, and health literacy improvement. The control group will receive routine primary care services without additional intervention.
Data will be collected at two time points: baseline (pre-test) and 4-6 weeks after the completion of the intervention (post-test). Outcome measures include self-efficacy, assessed using the General Self-Efficacy Scale; healthy lifestyle behaviors, assessed using the Health-Promoting Lifestyle Profile; and health literacy, assessed using the Health Literacy Scale (short form).
The study is expected to provide evidence on the effectiveness of theory-based educational interventions in promoting health behaviors and improving health literacy among older adults in primary care settings.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Van
-
Van, Van, Türkei (türkiye), 65100
- Tuşba Bardakçı Family Health Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Aged 65 years and older
- Able to communicate in Turkish
- Willing to participate and provide informed consent
- Having sufficient cognitive ability to follow the education program
Exclusion Criteria:
- Severe cognitive impairment
- Severe psychiatric disorder
- Acute or life-threatening medical condition
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Intervention Group
Participants in this group will receive a structured Social Cognitive Theory-based education program consisting of three weekly face-to-face sessions, in addition to routine primary care services.
|
A structured face-to-face education program based on Social Cognitive Theory, delivered in three weekly sessions covering health promotion, nutrition, physical activity, self-efficacy, and health literacy.
|
|
Kein Eingriff: Arm Type: Control Group (No Intervention)
Participants in this group will receive routine primary care services without any additional educational intervention.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Self-Efficacy Level
Zeitfenster: Baseline and 4-6 weeks after intervention
|
Self-efficacy will be assessed using the General Self-Efficacy Scale (GSES).
The scale consists of 10 items scored on a 4-point Likert scale (1-4), with a total score ranging from 10 to 40.
Higher scores indicate higher levels of self-efficacy (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Healthy Lifestyle Behaviors
Zeitfenster: Baseline and 4-6 weeks after intervention
|
Healthy lifestyle behaviors will be measured using the Health-Promoting Lifestyle Profile II (HPLP-II).
The scale includes 52 items rated on a 4-point Likert scale (1-4), with total scores ranging from 52 to 208.
Higher scores indicate more positive health-promoting lifestyle behaviors (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Health Literacy Level
Zeitfenster: Baseline and 4-6 weeks after intervention
|
Health literacy will be assessed using the Health Literacy Scale-Short Form (HLS-SF).
The scale consists of items rated on a Likert-type scale, with total scores ranging from 0 to 50.
Higher scores indicate higher health literacy levels (better outcome).
|
Baseline and 4-6 weeks after intervention
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Nutbeam D. Health literacy as a public health goal: 25 years on. Health Promot Int. 2025 Jul 1;40(4):daaf119. doi: 10.1093/heapro/daaf119. No abstract available.
- Sorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, Fullam J, Kondilis B, Agrafiotis D, Uiters E, Falcon M, Mensing M, Tchamov K, van den Broucke S, Brand H; HLS-EU Consortium. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015 Dec;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2026-228384
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .